StartupsInc42about 1 hour ago
Truemeds in Talks to Buy DealShare at $90 Mn
3 min read
Truemeds is in advanced talks to acquire DealShare via a share swap valuing the ecommerce startup at just over $90 Mn, about 95% below its 2022 peak of $1.7 Bn. Truemeds would issue shares at a $600 Mn valuation, with DealShare's cash reserves central to the deal.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
